APC mutation spectrum of Norwegian familial adenomatous polyposis families: high ratio of novel mutations

作者：Andresen Per Arne^*; Heimdal Ketil; Aaberg Kristin; Eklo Kristin; Ariansen Sarah; Silye Alexandra; Fausa Olav; Aabakken Lars; Aretz Stefan; Eide Tor J; Gedde Dahl Tobias Jr

来源：Journal of Cancer Research and Clinical Oncology, 2009, 135(10): 1463-1470.

DOI：10.1007/s00432-009-0594-4

• Adenomatous polyposis coli
• Familial adenomatous polyposis
• Novel mutations
• Germline mutations
• DHPLC

Familial adenomatous polyposis (FAP) is an autosomal dominantly inherited disease caused by mutations in the adenomatous polyposis coli (APC) gene. Massive formation of colorectal adenomas, of which some will inevitably develop into adenocarcinomas, is the hallmark of the disease. Characterization of causative APC mutations allows presymptomatic diagnosis, close follow-up and prophylactic intervention in families. To date more than 900 different germline mutations have been characterized worldwide demonstrating allelic heterogeneity.
The germline mutation spectrum of APC identified in 69 apparently unrelated Norwegian FAP families are presented and discussed with reference to clinical phenotype and novel mutation rate.
Different methods have been used over the years. However, all mutations were confirmed detectable by an implemented denaturing high-performance liquid chromatography screening approach. Multiplex ligation-dependent probe amplification analysis was employed for potential gross rearrangements.
Fifty-three distinctive mutations were detected, of which 22 have been detected in Norway exclusively. Except for two major deletion mutations encompassing the entire APC, all mutations resulted in premature truncation of translation caused by non-sense (31%) or change in reading frame (69%).
A high ratio of novel APC mutations continues to contribute to APC mutation heterogeneity causing FAP. This is the first comprehensive report of APC germline mutation spectrum in Norway.

• 出版日期2009-10